3/27
05:00 pm
mrkr
Form 8-K Marker Therapeutics, For: Mar 21
Neutral
Report
Form 8-K Marker Therapeutics, For: Mar 21
3/4
05:08 pm
mrkr
Form 8-K/A Marker Therapeutics, For: Feb 12
High
Report
Form 8-K/A Marker Therapeutics, For: Feb 12
2/19
05:02 pm
mrkr
Form 8-K Marker Therapeutics, For: Feb 12
Low
Report
Form 8-K Marker Therapeutics, For: Feb 12
2/14
05:20 pm
mrkr
Form 4 Marker Therapeutics, For: Feb 12 Filed by: Knobil Katharine
Medium
Report
Form 4 Marker Therapeutics, For: Feb 12 Filed by: Knobil Katharine
2/14
05:20 pm
mrkr
Form 4 Marker Therapeutics, For: Feb 12 Filed by: ELMS STEVE
Medium
Report
Form 4 Marker Therapeutics, For: Feb 12 Filed by: ELMS STEVE
2/14
05:18 pm
mrkr
Form 4 Marker Therapeutics, For: Feb 12 Filed by: Eansor Norman David
Medium
Report
Form 4 Marker Therapeutics, For: Feb 12 Filed by: Eansor Norman David
2/14
05:17 pm
mrkr
Form 4 Marker Therapeutics, For: Feb 12 Filed by: Vera Juan
Medium
Report
Form 4 Marker Therapeutics, For: Feb 12 Filed by: Vera Juan
2/14
05:10 pm
mrkr
Form SCHEDULE 13G Marker Therapeutics, Filed by: Blue Owl Capital Holdings LP
Medium
Report
Form SCHEDULE 13G Marker Therapeutics, Filed by: Blue Owl Capital Holdings LP
2/14
04:27 pm
mrkr
Form SCHEDULE 13G Marker Therapeutics, Filed by: Alyeska Investment Group, L.P.
Medium
Report
Form SCHEDULE 13G Marker Therapeutics, Filed by: Alyeska Investment Group, L.P.
2/4
04:06 pm
mrkr
Form DEFA14A Marker Therapeutics,
Medium
Report
Form DEFA14A Marker Therapeutics,
2/4
04:05 pm
mrkr
Form DEF 14A Marker Therapeutics, For: Mar 21
Medium
Report
Form DEF 14A Marker Therapeutics, For: Mar 21
1/30
04:05 pm
mrkr
Form 8-K Marker Therapeutics, For: Jan 24
Medium
Report
Form 8-K Marker Therapeutics, For: Jan 24
1/21
06:02 am
mrkr
Form EFFECT Marker Therapeutics,
High
Report
Form EFFECT Marker Therapeutics,
1/17
04:13 pm
mrkr
Form 424B3 Marker Therapeutics,
High
Report
Form 424B3 Marker Therapeutics,
1/13
04:05 pm
mrkr
Form PRE 14A Marker Therapeutics, For: Mar 21
Medium
Report
Form PRE 14A Marker Therapeutics, For: Mar 21
1/10
05:09 pm
mrkr
Form S-3 Marker Therapeutics,
Medium
Report
Form S-3 Marker Therapeutics,
12/30
04:47 pm
mrkr
Form D Marker Therapeutics,
Medium
Report
Form D Marker Therapeutics,